Divi’s Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential.
Positive Breakout: These 3 stocks cross above their 200 DMAs
In the NSE Midcap pack, three stocks’ close prices crossed above their 200 DMA (Daily Moving Averages) on February 5, according to stockedge.com’s technical scan